Xtant Medical Holdings Inc Cash Flow Conversion Efficiency
Xtant Medical Holdings Inc cash flow conversion efficiency. Based on the latest financial reports, Xtant Medical Holdings Inc (XTNT) has a cash flow conversion efficiency ratio of 0.106x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($5.38 Million) by net assets ($50.95 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Xtant Medical Holdings Inc (2008–2025)
Cash flow conversion efficiency of Xtant Medical Holdings Inc from 2008 to 2025. This chart illustrates how Xtant Medical Holdings Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. View latest Xtant Medical Holdings Inc stock price today for real-time trading data and today's change.
Xtant Medical Holdings Inc Cash Flow Conversion Ratio Explained
Xtant Medical Holdings Inc cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Xtant Medical Holdings Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Xtant Medical Holdings Inc ranked by their cash flow conversion efficiency. Also see XTNT company net worth for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Land Securities Group PLC
LSE:LAND
|
0.029x |
|
Single Well Industrial
TWO:3490
|
-0.002x |
|
INSUN Environmental New Technology Co. Ltd
KQ:060150
|
0.010x |
|
FALCON METALS LTD
F:E47
|
N/A |
|
KAISER REEF LTD.
F:7YR
|
N/A |
|
Uno&Company.Ltd
KQ:114630
|
0.013x |
|
Turbogen Chp
TA:TURB
|
1.208x |
|
RoyalTek Co Ltd
TWO:3306
|
-0.005x |
Annual Cash Flow Conversion Efficiency for Xtant Medical Holdings Inc (2008–2025)
The table below shows the annual cash flow conversion efficiency of Xtant Medical Holdings Inc from 2008 to 2025. Review cash generation quality of Xtant Medical Holdings Inc to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $50.95 Million | $12.55 Million | 0.246x | +188.93% |
| 2024-12-31 | $42.96 Million | $-11.90 Million | -0.277x | -49.43% |
| 2023-12-31 | $51.35 Million | $-9.52 Million | -0.185x | -18.55% |
| 2022-12-31 | $34.17 Million | $-5.34 Million | -0.156x | -1199.56% |
| 2021-12-31 | $30.88 Million | $439.00K | 0.014x | +128.22% |
| 2020-12-31 | $14.51 Million | $-731.00K | -0.050x | -639.08% |
| 2019-12-31 | $-44.20 Million | $-413.00K | 0.009x | +133.74% |
| 2018-12-31 | $-43.77 Million | $1.21 Million | -0.028x | -399.22% |
| 2017-12-31 | $-58.70 Million | $-543.18K | 0.009x | -99.55% |
| 2016-12-31 | $-7.07 Million | $-14.41 Million | 2.037x | +298.69% |
| 2015-12-31 | $8.88 Million | $-9.10 Million | -1.025x | -208.83% |
| 2014-12-31 | $-7.77 Million | $-7.32 Million | 0.942x | -35.61% |
| 2013-12-31 | $-3.84 Million | $-5.62 Million | 1.463x | +157.37% |
| 2012-12-31 | $4.23 Million | $-10.79 Million | -2.550x | -90.53% |
| 2011-12-31 | $5.50 Million | $-7.36 Million | -1.338x | -109.90% |
| 2010-12-31 | $-619.24K | $-8.37 Million | 13.520x | +1825.08% |
| 2009-12-31 | $4.68 Million | $-3.67 Million | -0.784x | -123.00% |
| 2008-12-31 | $11.34K | $38.64K | 3.407x | -- |
About Xtant Medical Holdings Inc
Xtant Medical Holdings, Inc. provides regenerative medicine products and medical devices for orthopedic and neurological surgeons in the United States and internationally. It offers OsteoSponge, a natural scaffold for cellular in-growth; OsteoSelect DBM Putty, a moldable demineralized bone matrix; OsteoSelect PLUS DBM Putty to deliver handling properties and ensure patient safety through validate… Read more